» Authors » Philippe Peruzzi

Philippe Peruzzi

Explore the profile of Philippe Peruzzi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 20
Citations 846
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Laigle-Donadey F, Metellus P, Guyotat J, Menei P, Proust F, Dufour H, et al.
J Neurosurg . 2022 Oct; 138(5):1199-1205. PMID: 36242578
Objective: The role of surgery in the treatment of malignant gliomas in the elderly is not settled. The authors conducted a randomized trial that compared tumor resection with biopsy only-both...
2.
Rigoard P, Ounajim A, Goudman L, Wood C, Roulaud M, Page P, et al.
J Clin Med . 2022 Oct; 11(19). PMID: 36233439
Spinal cord stimulation (SCS) is an effective and validated treatment to address chronic refractory neuropathic pain in persistent spinal pain syndrome-type 2 (PSPS-T2) patients. Surgical SCS lead placement is traditionally...
3.
Rigoard P, Billot M, Ingrand P, Durand-Zaleski I, Roulaud M, Peruzzi P, et al.
Neuromodulation . 2020 Sep; 24(1):86-101. PMID: 32865344
Background: Recent studies have highlighted multicolumn spinal cord stimulation (SCS) efficacy, hypothesizing that optimized spatial neural targeting provided by new-generation SCS lead design or its multicolumn programming abilities could represent...
4.
Vucurovic K, Emeriau S, Coulon J, Peruzzi P, Litre C, Kaladjian A
J Neurol Sci . 2017 Jun; 378:167-169. PMID: 28566157
No abstract available.
5.
Pallud J, Audureau E, Blonski M, Sanai N, Bauchet L, Fontaine D, et al.
Brain . 2013 Dec; 137(Pt 2):449-62. PMID: 24374407
Diffuse low-grade gliomas are highly epileptogenic brain tumours. We aimed to explore the natural course of epileptic seizures, their predictors and the prognostic significance of their occurrence in adult patients...
6.
Capelle L, Fontaine D, Mandonnet E, Taillandier L, Golmard J, Bauchet L, et al.
J Neurosurg . 2013 Mar; 118(6):1157-68. PMID: 23495881
Object: The spontaneous prognostic factors and optimal therapeutic strategy for WHO Grade II gliomas (GIIGs) have yet to be unanimously defined. Specifically, the role of resection is still debated, most...
7.
Blonski M, Pallud J, Goze C, Mandonnet E, Rigau V, Bauchet L, et al.
J Neurooncol . 2013 Mar; 113(2):267-75. PMID: 23479036
The involvement of eloquent brain areas may preclude the total/subtotal surgical resection of diffuse low-grade gliomas (DLGGs). The feasibility and functional tolerance of neoadjuvant chemotherapy have been demonstrated in such...
8.
Pallud J, Blonski M, Mandonnet E, Audureau E, Fontaine D, Sanai N, et al.
Neuro Oncol . 2013 Feb; 15(5):595-606. PMID: 23393207
Background: Supratentorial diffuse low-grade gliomas present a slow macroscopic tumor growth that can be quantified through the measurement of their velocity of diametric expansion. We assessed whether spontaneous velocity of...
9.
Litre F, Rousseaux P, Jovenin N, Bazin A, Peruzzi P, Wdowczyk D, et al.
Radiother Oncol . 2012 Dec; 106(2):169-74. PMID: 23219253
Purpose: To evaluate long-term outcomes and efficacy of fractionated stereotactic radiotherapy in the treatment of acoustic neuromas. Material And Methods: Between January 1996 and December 2009, 158 acoustic neuromas were...
10.
Duntze J, Litre C, Eap C, Theret E, Debreuve A, Jovenin N, et al.
Ann Surg Oncol . 2012 Dec; 20(6):2065-72. PMID: 23212763
Objectives: Study the feasibility and effectiveness of a treatment associated surgery, intraoperative chemotherapy (carmustine wafers), and concomitant radiochemotherapy (temozolomide) for the management of newly diagnosed, high-grade gliomas. Methods: Prospective multicenter...